PMC:7445716 / 75850-76099 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T693","span":{"begin":84,"end":87},"obj":"Disease"},{"id":"T694","span":{"begin":212,"end":222},"obj":"Disease"}],"attributes":[{"id":"A693","pred":"mondo_id","subj":"T693","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A694","pred":"mondo_id","subj":"T694","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"This feature, together with the frequently reported negative nasopharyngeal swab at GBS onset [22, 24, 36, 44, 45, 52] and clinical improvement after IVIG therapy, seems to support the notion of a prominent post-infectious immune-mediated mechanism."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T686","span":{"begin":95,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T687","span":{"begin":103,"end":105},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T688","span":{"begin":111,"end":113},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T689","span":{"begin":115,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T690","span":{"begin":195,"end":196},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"This feature, together with the frequently reported negative nasopharyngeal swab at GBS onset [22, 24, 36, 44, 45, 52] and clinical improvement after IVIG therapy, seems to support the notion of a prominent post-infectious immune-mediated mechanism."}

{"project":"LitCovid-sentences","denotations":[{"id":"T454","span":{"begin":0,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This feature, together with the frequently reported negative nasopharyngeal swab at GBS onset [22, 24, 36, 44, 45, 52] and clinical improvement after IVIG therapy, seems to support the notion of a prominent post-infectious immune-mediated mechanism."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1147","span":{"begin":61,"end":75},"obj":"UBERON:0001728"},{"id":"T1148","span":{"begin":150,"end":154},"obj":"CHEBI:42098;CHEBI:42098"},{"id":"T1149","span":{"begin":223,"end":229},"obj":"UBERON:0002405"}],"text":"This feature, together with the frequently reported negative nasopharyngeal swab at GBS onset [22, 24, 36, 44, 45, 52] and clinical improvement after IVIG therapy, seems to support the notion of a prominent post-infectious immune-mediated mechanism."}

{"project":"2_test","denotations":[{"id":"32840686-32749602-63205832","span":{"begin":94,"end":96},"obj":"32749602"},{"id":"32840686-32558002-63205833","span":{"begin":98,"end":100},"obj":"32558002"},{"id":"32840686-32753154-63205834","span":{"begin":102,"end":104},"obj":"32753154"},{"id":"32840686-32503084-63205835","span":{"begin":106,"end":108},"obj":"32503084"},{"id":"32840686-32638112-63205836","span":{"begin":110,"end":112},"obj":"32638112"},{"id":"32840686-32302082-63205837","span":{"begin":114,"end":116},"obj":"32302082"}],"text":"This feature, together with the frequently reported negative nasopharyngeal swab at GBS onset [22, 24, 36, 44, 45, 52] and clinical improvement after IVIG therapy, seems to support the notion of a prominent post-infectious immune-mediated mechanism."}